MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Autonomic failure and circadian rhythm of arterial blood pressure in IDIOPATHIC REM behaviour disorders and Parkinson’s disease

    R. Zangaglia, E. Guaschino, N. Ghiotto, B. Minafra, M. Terzaghi, G. Capone, A. Spiritelli, D. Bosone, C. Pacchetti (Pavia, Italy)

    Objective: Aim of our study is to correlate the autonomic nervous system failure and circadian rhythm of arterial blood pressure in idiopathic REM behaviour disorders…
  • 2016 International Congress

    Influence of onset age on the progression of non-motor symptoms in Parkinson’s disease: A prospective study from Southwest China

    R. Ou, B. Cao, Q. Wei, K. Chen, W. Song, J. Yang, B. Zhao, Y. Wu, H. Shang (Chengdu, People's Republic of China)

    Objective: To explore the influence of onset age on the progression of non-motor symptoms (NMS) in Parkinson's disease. Background: NMS are gaining increasing relevance in…
  • 2016 International Congress

    Cerebral vasoreactivity in Parkinson’s disease and multiple system atrophy: A pilot study

    E. Indelicato, F.E. Pontieri, D. Benincasa, A. Fanciulli, F. Orzi, M. Giovannelli, G. Sette (Rome, Italy)

    Objective: To compare cerebral vasoreactivity in Parkinson´s disease (PD) and multiple system atrophy (MSA) patients with or without cardiovascular autonomic failure (CAF). Background: CAF is…
  • 2016 International Congress

    Comorbidity and Parkinson’s disease phenotype, dopaminergic function and CSF biomarkers

    T. Yousaf, G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

    Objective: To evaluate the influence of comorbidity on clinical phenotype, dopaminergic function and CSF biomarkers in a population of de novo Parkinson's disease (PD) patients.…
  • 2016 International Congress

    Is there any relationship between olfactory dysfunction and memory disorder?

    H. Onuma, Y. Kobayashi, A. Kumon, K. Hasegawa (Sagamihara-city, Japan)

    Objective: To clarify the relationship between non-motor symptoms and memory disorder in 160 cases with PD without cognitive decline in our out-patients clinic. Background: Both…
  • 2016 International Congress

    Do subjective ratings of the Parkinson’s disease sleep scale-2 converge with results from polysomnography in early Parkinson’s disease? – A report from the DeNoPa cohort

    F. Sixel-Döring, J. Zimmermann, M.L. Muntean, B. Mollenhauer, C. Trenkwalder (Kassel, Germany)

    Objective: To test whether subjective sleep perception is associated with objective sleep parameters by comparing video-polysomnographic (vPSG) data from Parkinson's disease (PD) patients with scorings…
  • 2016 International Congress

    The prevalence of constipation and irritable bowel syndrome in Parkinson’s disease patients according to Rome III diagnostic criteria

    T. Mishima, J. Fukae, S. Fujioka, K. Inoue, Y. Tsuboi (Fukuoka, Japan)

    Objective: To assess the prevalence of constipation and irritable bowel syndrome (IBS) in Parkinson's disease (PD) patients using Rome III in our cohort. Background: Gastrointestinal…
  • 2016 International Congress

    Comprehensive motor and non-motor staging system in Parkinson’s disease: Results from a global cross-sectional study

    C. Rodriguez-Blazquez, A. Rizos, K.R. Chaudhuri, P. Martinez-Martin, NILS, EUROPAR and MDS Non-Motor PD Study Groups (Madrid, Spain)

    Objective: To describe a sample of Parkinson's disease (PD) patients by means of a combined, comprehensive, motor and non-motor staging system. Background: PD severity is…
  • 2016 International Congress

    Use of the physiotherapy in the treatment of initial stages of Parkinson’s disease

    O.L. Tondiy (Kharkiv, Ukraine)

    Objective: Stage of Parkinson's disease was determined by the Hoehn&Yahr Scale. Background: The effect of the low-frequent variable magnetic field, the ultratonetherapy and balneotherapy on…
  • 2016 International Congress

    Survey of prodromal symptoms of Parkinson’s disease in Japan

    M. Yogo, M. Morita, M. Suzuki (Katsushika-ku, Japan)

    Objective: To reveal prodromal symptoms at a public seminar for PD via questionnaires. Background: How to select subjects with PD for disease modify therapy in…
  • « Previous Page
  • 1
  • …
  • 1360
  • 1361
  • 1362
  • 1363
  • 1364
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley